DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Mathias SD, Li X, Eisen M, Carpenter N, Crosby RD, Blanchette VS.
A phase 3, randomized, double-blind, placebo-controlled study to determine the effect of romiplostim on health-related quality of life in children with primary immune thrombocytopenia and associated burden in their parents.
Pediatr Blood Cancer 2016;
63 (07) 1232-1237
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.